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ABSTRACT 
 
This report aims to outline and summarise some of the practical experiences from the major 
Regulatory agencies as well as the guidance so far developed by the OECD. Definitions for some of 
the common terms such as read across and chemical categories are provided. Recommendations for 
further work are highlighted.  Regulatory use of read across/chemical category is still quite limited. A 
clear need is the development of practical guidance to promote greater uptake of these types of these 
approaches.  
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BASIC CONCEPTS 
The underlying premise underpinning all Structure Activity relationships (SAR) is the expectation 
that structurally similar chemicals will have similar physical attributes and biological effects. 
Definitions 
A Read-across/analogue approach typically involves using data/information on one chemical 
structure and making some assessment about the relevance of that information for a second chemical 
structure. It is the process by which one or more properties of a given chemical are inferred by 
comparison of that chemical with a chemical(s) of similar molecular structure(s) and physicochemical 
properties, for which the properties of interest are known. This approach can be used to assess 
physicochemical properties, toxicity, environmental fate and eco-toxicity.    
 
The read-across can be performed qualitatively or quantitatively: 
Qualitative read-across can be regarded as the application of SAR. The process involves:  
a) the identification of a chemical substructure that is common to the two substances (which are 
therefore analogues); and  
b) the assumption that the presence (or absence) of a property/activity for a substance can be inferred 
from the presence (or absence) of the same property/activity for an analogous substance.  
This assumption implies that analogues behave qualitatively similarly, and is usually the result of an 
expert judgement evaluation. 
Quantitative read-across involves the identification of a chemical substructure that is common to the 
two substances (which are therefore analogues), and the assumption that the known value of a 
property for one substance can be used to estimate the unknown value of the same property for 
another substance. This assumption implies that the potency of an effect shared by different 
analogous substances is similar, and is also usually the result of an expert judgement evaluation.  
 
SAR and QSAR: A (Q)SAR consists of a relationship between the chemical structure, or physical-
chemical representations thereof and the outcome in a test for an endpoint (biological or other 
physicochemical. property). They can be divided into two major types, QSARs and SARs. 
 
SARs are qualitative relationships in the form of structural alerts that incorporate molecular 
substructures or fragments related to the presence or absence of activity. 
They normally involves use data from a training set of many chemicals and their structures, the 
development of rules based on "expert judgement" and then applying the rules to another chemical 
structure. 
 
QSARs are quantitative models yielding a continuous or categorical result. The most common 
techniques for developing QSARs are regression analysis, neural nets and classification methods. 
Examples of regression analysis include ordinary least squares and partial least squares. Examples of 
classification methods are discriminant analysis, decision trees and distance based methods of 
similarity analysis. QSARs normally involve the development of a mathematical (statistical) based 
equation, based on the data from a training set of many chemicals and their structures/properties, 
which may then be applied to another chemical structure. 
 
The major difference between these approaches and those described for analogue/read across, are that 
a (Q)SAR is often based on larger numbers of chemicals and tends to be more formalised in its 
description.   
 
A chemical category is a group of chemicals whose physicochemical and toxicological (including 
ecotoxicological) properties are likely to be similar or follow a regular pattern as a result of structural 
similarity. These structural similarities may create a predictable pattern in any or all of the following 
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parameters: physicochemical properties, environmental fate and environmental effects, and/or human 
health effects. The similarities may be based on the following: 
• a common functional group (e.g., aldehyde, epoxide, ester, etc.) related to specific 
activity; or  
• the likelihood of common precursors and/or breakdown products, via physical or 
biological processes, which result in structurally similar chemicals (e.g., the "family 
approach" of examining related chemicals such as acid/ester/salt); and  
• an incremental and constant change across the category (e.g., the methylene group 
difference between adjacent members of the alpha-olefins).  
Within a category different members may be selected for the endpoint desired. If the available test 
results show that the chemicals in a category behave in a similar or predictable manner, then 
interpolation and/or extrapolation may be used to assess the chemicals instead of conducting 
additional testing.  
 
Evaluation of Analogues/Read-across and Chemical Category approaches  
Analogues/read-across 
Since a read across may involve as little as two chemicals, only the data for the first chemical needs 
to be known together with the detailed reasoning behind the comparison.   
 
Chemical categories 
The robustness of a chemical category could be evaluated in a similar way to that of QSARs. The 
features that relate the category members is assessed together with an assessment of the scope of the 
category. In principle, a representative set of chemicals within the scope could be identified and tested 
in the same way as would be done for an external validation of a QSAR.  
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Use IN EU  
UK 
UK experience that is currently known about in the use of read across comes principally from the 
Health and Safety Executive (HSE) and the UK Environmental Agency. 
The HSE follows a series of needs and principles that were laid out by Hanway and Evans in 2000.  
There are a number of steps which are followed on a case-by-case basis. Firstly a chemical is 
evaluated on the basis of its structural similarity e.g. Is there an absence or presence of specific 
functional groups that might modify the likely activity/toxicity expressed?   
Hence the purity and impurity profile is considered to judge whether this might have an impact on the 
toxicity profile. The physicochemical properties are compared since properties such Log P, aqueous 
solubility may provide insights to the likely absorption characteristics of a chemical. The likely 
toxicokinetics are evaluated to consider how stable the chemical is and whether it will metabolise, 
decompose or hydrolyse in some manner. DEREK for Windows, the knowledge based expert system 
is used to identify structural alerts if any. All available toxicological information is collated and 
assessed.  
These steps are considered in turn and form the basis of any read across argument. Typically some 
toxicity testing is requested to confirm the validity of the read across; an acute oral toxicity study and 
an Ames test are conducted. If the results of these studies are different, then further testing is 
conducted. 
 
Several conclusions have resulted from this approach: a) acute oral toxicity testing and Ames testing 
has been effective in underpinning a read across argument; b) for regulatory purposes it is usually 
easer to read across positive data; c) two extremes in a series are sufficient to define the domain; and 
d) new tests should not be conducted to remove unwanted classifications. 
 
Suggestions for the further development of guidance 
This approach has been demonstrated to be useful in reading across a number of chemicals under 
NONs on a case-by-case basis. It could be potentially extended to help formulate larger groupings of 
chemicals as initial categories.  
However what is not apparent from the information available are the practical steps of how a read 
across analog is selected or whether mechanistic considerations are accounted for in this selection.  
Further information on how analogues are selected would be helpful to understand the overall 
approach better and what modifications may be required in order for EU guidance to be drafted for 
REACH.  
 
References: 
Hanway, R.H. & Evans, P.F. (2000). Read-across of toxicological data in the notification of new 
chemicals. Toxicology Letters 116(S1), 61. 
 
Potts RO, Guy RH. (1992). Predicting skin permeability. Pharm Res. 9(5), 663-669. 
 
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ.(2001). Experimental and computational 
approaches to estimate solubility and permeability in drug discovery and development settings. Adv 
Drug Deliv Rev. 46(1-3), 3-26. 
 
The UK Environmental Agency have a similar approach to read across as the HSE though 
appropriate ecotoxicity tests such as acute toxicity to Daphnia form the basis of establishing the 
validity of their read acrosses.The approach is also a step-by-step one. Structural similarity is assessed 
including an evaluation of whether there are any additional functional groups (or absence of groups) 
that might modify the toxicity. Then the purity and impurity profile is assessed. An evaluation of the 
physicochemical properties is made along with an assessment of how these properties may drive 
 9 
ecotoxicity. QSARs for determining the likely toxicity of analogues are used. Basic toxicity tests such 
as acute toxicity to Daphnia are conducted to confirm the validity of a read across. In contrast to the 
approach by HSE, additional testing may be conducted to remove unwanted classifications.  
 
Suggestions for the further development of guidance 
The evaluation of physicochemical properties is highlighted as a useful means to evaluate similarity 
as these types of parameters often drive the ecotoxicity response – this reflects mechanistic thinking 
that is employed in the read across. Examples mentioned included water solubility and Log P the 
octanol/water partition coefficient. This approach has been demonstrated to be very useful in reading 
across a number of chemicals under NONs on a case by case basis. The basis of this read across 
approach appears robust as mechanistic principles are implicitly embedded though further 
information that details how chemicals are selected for read across or what similarity approaches are 
used would be useful.  
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OECD GUIDANCE  
Guidance on the formation and use for chemical categories for fulfilling data requirements has been 
published by the OECD as part of the OECD Manual for Investigation for HPV Chemicals (OECD, 
2004). This guidance is used among others for fulfilling the data requirements within the OECD HPV 
Chemicals Programme. The same guidance document is published by the US EPA for use within the 
US HPV Challenge Programme. The OECD guidance document was revised during 2004 and 2005. 
 
The revised guidance document addresses the following issues: 
– definitions and explanations of the chemical category concept 
– general approach for developing categories 
– differences in grouping for different endpoints 
– use of QSARs for the development of a category 
– guidance on different types of categories (i.e. chain-length, metabolic pathways, 
isomers and their mixtures, complex substances, metal and metal compounds) 
 
The guidance document also provides a number of examples of categories that have been adopted 
within the OECD HPV Chemicals Programme or are currently under preparation: 
– Alpha-olefins - discrete chemicals with an incremental and constant change across the 
category 
– Linear alkyl benzenes - family of mixtures 
– Brominated diphenyl ethers - family of congeners 
– Butenes – family of isomers and their mixtures 
– Hydrocarbon solvents – family of complex mixtures 
– Inorganic nickel compounds 
General Suggestions for the further development of guidance 
The main limitations of the revised guidance document (July 2005) are: 
− Absence of systematic approach for category identification. The formation of chemical 
categories has been largely influenced by practical considerations such as the substances 
produced by the member of the industry consortium preparing the assessment. Although 
tools to systematically identify analogues within a large list of substances (e.g. OECD 
HPV List or EINECS) are being developed, they are not being used systematically.  
− Absence of quantitative validation criteria. While the guidance document gives 
qualitative guidance for deciding whether a category is robust (e.g. establishment of a 
pattern for the results for a given endpoint across the members of the category), the 
decision remains largely an expert judgement.  
− Tentative guidance on quantitative filling of data gaps. The guidance document 
provides only tentative guidance on how data gaps could be filled quantitatively by 
read-across, extrapolation or interpolation.  
− Limited guidance for complex substances. Only tentative guidance with limited 
examples is provided for complex multi-component substances (mixtures) and metal 
compounds, in spite of the fact that these are types of compounds where this approach is 
currently used. 
 
 
Guidance on the Development and Use of Chemical Categories in the HPV Chemicals 
Programme 
 
Guidance on the formation and use for chemical categories for fulfilling data requirements has been 
published by the OECD as part of the OECD Manual for Investigation for HPV Chemicals (OECD, 
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2004). This guidance is used among others for fulfilling the data requirements within the OECD HPV 
Chemicals Programme where there are more than 5000 chemical substances on the OECD List.  
 
Definitions 
 
A chemical category is a group of chemicals whose physicochemical and toxicological properties are 
likely to be similar or follow a regular pattern as a result of structural similarity. These structural 
similarities may create a predictable pattern in any or all of the following parameters: 
physicochemical properties, environmental fate and environmental effects, and human health effects. 
The similarities may be based on the following: 
 a common functional group (e.g., aldehyde, epoxide, ester, metal ion, etc.); or 
 the likelihood of common precursors and/or breakdown products, via physical or biological 
processes, which result in structurally similar chemicals (e.g., the “metabolic series approach” 
of examining related chemicals such as acid/ester/salt); and, 
 an incremental and constant change across the category (e.g. a chain-length category).  
 
The applicability domain of a chemical category defines the physicochemical property space within 
which the chemical category is considered to be valid. The applicability domain is a concept 
borrowed from the QSAR field. In the context of a chemical category, it can be considered to define 
the ranges of physicochemical, environmental, toxicological and/or ecotoxicological properties within 
which reliable estimations can be made of missing data points, by the use of trend analysis 
(interpolations and/or extrapolations), read-across, structure-activity relationships (SAR), quantitative 
structure-activity relationships (QSAR), activity-activity relationships (AAR). To illustrate the 
concept of applicability domain, it might be observed that the category of ethylene glycols show 
trends in certain properties in proportion to the chain length of the glycols, but that these trends are 
only applicable within a defined range of chain lengths.  
 
A chemical category can be represented graphically as a two-dimensional matrix in which different 
category members occupy different columns, and the different category endpoints occupy different 
rows (Figure 1). Data gaps can be filled in by one or more of the following procedures: qualitative 
read-across, quantitative read-across, use of SARs, use of QSARs. 
 
Read-across can be regarded as using data available for some members of a category to estimate 
values (qualitatively or quantitatively) for category members for which no such data exists. 
Qualitative read-across can be regarded as the application of SAR by using data that are 
internal to the chemical category. The process involves: a) the identification of a chemical 
substructure that is common to two or more members of the category (which are therefore 
analogues); and b) the assumption that the presence (or absence) of a property/activity for a 
member can be inferred from the presence (or absence) of the same property/activity for an 
analogous member. This assumption implies that analogues behave qualitatively similarly, 
and is usually the result of an expert judgement evaluation rather than a more formal 
(mathematical) analysis. 
 
Quantitative read-across involves the identification of a chemical substructure that is 
common to two or more members of the category (which are therefore analogues), and the 
assumption that the known value of a property for one member can be used to estimate the 
unknown value of the same property for another member. This assumption implies that the 
potency of an effect shared by different analogous chemicals is similar, and is usually the 
result of an expert judgement evaluation rather than a more formal (mathematical) analysis. 
 
SARs can also be applied by using data that are external to the chemical category. The process 
involves: a) the identification of a chemical substructure that is shared by a category member and by 
one or more chemicals (analogues) that do not belong to the category; and b) the prediction of the 
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presence or absence of an effect/activity for a category member on the basis of its similarity to the 
analogous chemicals (which are outside the category). Data from chemicals which are external to the 
category should not be used selectively for only those endpoints which support the category, unless 
justified on a scientific basis. 
 
QSARs can be applied by using data that are internal and/or external to the chemical category.  A 
QSAR is a model that makes predictions of an activity (or property) from a numerical measure of 
chemical structure (or physicochemical property).  
 
Trend analysis can be applied when the members of a category exhibit a series of increasing or 
decreasing values for a given endpoint. Interpolation is the estimation of a value for a member using 
measured values from other members on “both sides” of that member within the defined category 
spectrum (see Figure 1), whereas extrapolation refers to the estimation of a value for a member that is 
near or at the category boundary using measured values from internal category members (see Figure 
In general, interpolation between category members is preferred to extrapolation. However, in certain 
cases, such as where toxicity does not change among tested category members, extrapolation to other 
category members may be acceptable. Interpolation can be performed with a certain confidence when 
the series of values is monotonic (all increasing or decreasing), but guidance is needed in the case that 
one or more values are outliers to the trend. 
 
Figure 1  Graphical representation of a chemical category and ways of filling in data gaps 
 
Within a category different members can be selected to demonstrate the pattern or trend of interest - 
i.e., those selected for a category approach for environmental effects endpoints may not be suitable 
for assessing human health effect endpoints. Furthermore, within a category, correlations might be 
established for different members of the same category depending on the property. For example, for 
categories constituted of chemicals with increasing chain length, a trend might be seen for aquatic 
toxicity for the lower chain chemicals while a cut-off in toxicity is seen starting with a given chain 
length. On the other hand a correlation might be seen for another property (e.g. acute mammalian 
toxicity) over the whole category. 
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General Approach for Developing Categories 
 
HPV chemical category development is a step by step process which is described below. 
 
• Step 1: Define the category 
 
A category can be defined in a variety of ways. Traditionally, category definitions have 
referred to chemical classes (e.g. epoxides), but a category definition could also refer to a 
group of chemicals related by a particular property (e.g. surfactants) or mechanism of 
action (e.g. non-polar narcotics).  
 
Some categories (e.g. propyl series) have been defined in terms of a common metabolic 
pathway. An alternative way of treating the members of such categories would be to 
locate them in categories defined on a different basis (e.g. by chemical class), and to 
define the chemical and/or biochemical reactions that relate one category to another. In 
other words, it is debatable whether chemicals related by a kinetic process should be 
placed in a single category or in multiple categories, since the kinetic data could either 
confirm or undermine a category defined on a different basis. 
 
The category should also be described (characterised) in terms of: 
 
a) The relational features of the category, i.e. the chemical similarities (analogies) and 
trends in properties and/or activities that collectively generate an association 
between the members. The relational features can be regarded as the “connective 
tissue” that hold the category members together. Relational features include SARs, 
QSARs, AARs, examples of read-across, and examples of trend analysis 
(interpolations and extrapolations).  
 
b) The applicability domain of the category, i.e. a set of inclusion and/or exclusion 
rules that define the ranges of values within which reliable estimations can be made 
for category members 
 
Whilst the selection of a particular chemical category will normally be guided by the 
presence of a number of HPV chemicals in the category, it should be noted that a 
category may also contain other substances that are not HPV chemicals (or indeed, are 
not necessarily commercially available). These chemicals are legitimate candidates for 
the category, and may in some cases prove to be relevant candidates for further testing in 
order to evaluate the properties of the category as a whole. 
 
In identifying a category, it is important that all potential category members are 
described as comprehensively as possible. This is especially important where the group 
of chemicals is related by a particular property (e.g. surfactants) or mechanism of action 
(e.g. non-polar narcotics). 
 
For potential members of a category, all relevant CAS numbers should be selected. For 
some substances, there may be more than one CAS number, and studies may contain 
relevant data reported under different CAS numbers. Due to historic reporting errors, a 
CAS number used to describe a substance may not accurately describe the substance as 
marketed. The CAS numbers of members of the category should also be checked against 
different inventories (e.g. TSCA, Einecs, Elincs, Customs Inventories etc.) as these 
inventories can provide an indication as to whether or not the substances are marketed 
commercially.  
 
It is important that information on the purity and impurity profiles of all potential 
category members is collected at the same time as details of the molecular structure.  
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Differing purity or impurities could influence the overall toxicity.  For example, a 
category member may contain a particularly toxic impurity that is not present in the other 
substances making it difficult or impossible to draw conclusions on the toxicity of other 
substances in the category.  It is therefore important that category members have similar 
purity profiles or, where they differ, the effect of the differing purity profiles is known.   
 
• Step 2: Gather published and unpublished data for each category member. 
 
Gather published and unpublished data on physicochemical properties, environmental 
fate and effects, and health effects for each member of the category.  This should 
include all existing relevant data and not be limited to the SIDS endpoints (e.g., 
metabolism and cancer studies are relevant but not part of SIDS).  
 
• Step 3: Evaluate available data for adequacy.  
 
• Step 4: Construct a matrix of data availability.  
 
Construct a matrix of data availability  arranged in molecular weight order (or some 
other fashion indicating the structural progression of the category).  Indicate in the cells 
of the matrix whether data are available or unavailable, as well as the available key 
study results.  
 
• Step 5: Perform an internal assessment of the category. In this step, an internal 
assessment of the category is performed. The internal assessment consists of: 
a) identification of the relational features that collectively generate the association 
between the category members. These relational features are proposed on the basis 
of existing data, which may be internal and/or external to the category. 
 
b) use of the relational features to fill data gaps (empty cells in the category matrix) or 
fill in matrix cells containing data of uncertain quality. 
 
In this context, the term “internal” is borrowed from the QSAR field, in which the 
internal assessment of a QSAR model refers to an assessment of the model performance 
by using the same data that were used to develop the model. 
 
Evaluate the category approach to determine whether there is a correlation among 
category members and each endpoint by looking for patterns in the matrix.  The same 
category members do not have to be used for each evaluation, i.e., the members selected 
for environmental fate may be different from those used to evaluate toxicology effects. 
- If there are substantial data, i.e., adequate data for a given endpoint, but no 
apparent pattern, the proposed category may not be appropriate and so testing 
may be required for all remaining category members for that endpoint.  
However, an alternative category proposal may be developed (go back to Step 
1). 
- If there are substantial and adequate data that correlate well, the category may 
be appropriate and a category test plan proposal should be prepared (Step 6). 
- If substantial and adequate data do not exist, but the structure-based category is 
valid for one or more endpoints, then a category approach may still be proposed 
(go to Step 6). 
 
When establishing trends in data, laboratory and experimental variations should be 
considered.  Similar species/strains, endpoints and test protocols should be compared. 
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Deviations from a trend should be clearly identified and possible reasons for the 
deviations laid out in the category analysis.  
 
• Step 6: Prepare category test plan. 
Category test plans should include a category definition, rationale, and matrix of data 
availability and be accompanied by Dossiers for each category member. 
The rationale supporting a category definition should be as simple and transparent as 
possible, and should explain why the existing data and proposed testing data allows 
interpolation or extrapolation to other members of the category that have no data or 
proposed testing. 
The test plan needs to summarise the adequacy of the existing data, and how the 
proposed testing will adequately characterise the category. 
The matrix of data is an essential part of the test plan and provides a useful tool for 
consideration and presentation of the available data.  Assuming the endpoints are rows 
in the matrix, each row must have data in at least one cell.  Assuming the columns are 
the category members, one or more columns may have all empty cells, i.e. no test data 
available.  There are no rules for the number of columns and cells that must be filled nor 
the number that can be empty.  Acceptability of the matrix will depend on the number of 
members in the category, the endpoint, and the confidence in the interpolation and 
extrapolation. 
When selecting a sample to test, it should be representative of the substance marketed, 
including the presence of any manufacturing impurities.  
 
• Step 7:  Conduct the necessary testing. 
 
• Step 8:  Perform an external assessment of the category 
 
In this step, some or all of the relational features are assessed by checking whether the 
predictions they make for data gaps (or data points of dubious quality) are accurate on 
the basis of newly-generated experimental data, obtained in Step 7. 
 
In this context, the term “external” is being borrowed from the QSAR field, in which the 
external assessment of a model refers to an assessment of the model performance by 
using independent data that were not used to develop the model. 
 
 
• Step 9: Fill data gaps by read-across, extrapolation, interpolation etc. 
 
The way to fill data gaps through the category approach is specific to each category. No 
definitive guidance can be provided for the moment.  
QSARs could be used to support proposals for filling data gaps by any of the 
mechanisms described above.  
 
For categories composed of complex substances, approaches like the toxic equivalency 
factors or toxic units approach could be investigated. 
 
Specific Suggestions for the further development of guidance 
The OECD guidance is an excellent starting point in describing the principles and approaches of 
chemical categories. It does miss the specific technical input that would help an end user in starting to 
formulate a category i.e. what tools/resources are available that could facilitate that selection. The 
category description is largely limited to chemical classes, similar functional groups etc. Ideally this 
would be extended to a two-tiered approach to categories. On one simple level the category would be 
based on different measures of structural similarity (fingerprints, descriptors, pharmacophores etc) 
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with corresponding approaches or means by which a set of structures (potential analogues) could be 
identified. This first tier would describe the initial grouping. A second tier would focus in the 
parameters/descriptors driving a particular (eco)toxicity response i.e. mechanistically based 
groupings.  
The guidance does not provide any assistance in terms of resources for extracting data. There are 
some resources that permit the search and retrieval of information for chemicals on the basis of 
structure or substructure and these could be described to highlight the “how”. 
Some guidance on what is meant by “adequate” as this is a subjective term and open to many 
different interpretations. Perhaps a systematic/robust means of accounting for “adequacy” would be in 
terms of the uncertainty of the data available and the impact of that on the risk assessment decision 
under consideration. 
Use of QSARs for the Development of a Category 
 
Greater confidence and further demonstration of the category approach may be gained through 
applying appropriate QSAR models on all category members for a given endpoint.  QSARs can 
contribute at all stages of category development and consideration.   Based on experienced 
assessment of the quality of output taking into account limitations and strengths of a range of models, 
QSARs may contribute not only for endpoints and compounds within categories where there are no 
relevant data but also in the interpretation of weight of evidence for mixed datasets and analysis of 
trends.   
 
The output of QSAR modelling is particularly valuable in hypothesis generation and testing for step 
1, “identifying the structure based category and its members”.  In particular, the more transparent, 
evolving analytical models provide access to detailed description of relevant data in the training sets. 
This can facilitate initial consideration of trends to establish the nature and bounds of the category.  It 
is also conserving of resources since it avoids consideration at early stage of potentially large volumes 
of data on, for example, multiple endpoints for human health. It also permits hypothesis testing of 
several possible combinations and permutations for category definition.  
 
QSAR modelling can also assist at this stage in defining the appropriate bounds of the proposed 
category, through consideration of measures of similarity for chemical descriptors in the models.  In 
the more transparent, evolving analytical models, the bounds of this similarity can be specified and 
the category defined accordingly. In some cases, this can lead to the definition of a more extensive 
category than was originally envisaged. 
 
In addition, QSAR can in some cases be used to assess similarities in metabolic pathways across the 
group, and this information can be helpful in assessing similarities and differences within the 
category.  
 
Results of QSAR modelling are also relevant to step 2 (“Gathering published and unpublished data 
for each category member”). In addition to contributing to trends analysis for potential members of 
the category where no data have been identified, considered output of a battery of models can also 
add weight of evidence to increase confidence in trends analysis, where the pattern is not clear or 
consistent based on available data.  For example, evaluated QSAR output may contribute where dose 
spacing or comparability of experimental protocols in available studies for different members of the 
category precludes meaningful analysis of quantitative trends of effect levels. In compiling this 
information, however, it is important to distinguish where the models contribute additionally to 
identified experimental data – i.e., that they are not simply duplicating the information, based on 
replication of its inclusion in their training set. The ease with which this information can be accessed 
for various models (if at all) varies, depending upon degree of transparency.  
 
In relation to step 3 (“Evaluate available data for adequacy”), for QSAR modelling, this requires 
consideration of aspects related to the training sets and the models, themselves. Relevant aspects 
 17 
include criteria for inclusion of and nature of data in the training sets, the nature of the analysis for 
consideration of similarity, the criteria for weight of evidence for delineation of a positive/negative 
response and the nature of validation of the models and aspects thereof, including concordance, 
sensitivity and specificity for specific endpoints and subsets of chemicals.  For characterization of 
hazard for related endpoints, critically evaluated QSAR output can be combined with weighting of the 
endpoints themselves (e.g., in vivo versus in vitro genotoxicity) as a basis for meaningful contribution 
to hazard characterization, particularly where data are lacking or mixed. 
 
For step 4 (“Construct a matrix of data availability”), then, it will be important that results of QSAR 
modelling be clearly distinguished from those which are based on data.  As indicated above, only 
evaluated results of QSAR modelling which contribute additionally to weight of evidence 
determinations or quantitative trends analysis should be included.  This would include, then, only 
results for modelling, where predictive output informs additionally to the data (i.e., where evaluated 
output meaningfully contributes to weight of evidence or trend analysis – this could be for substances 
where there are no data or where datasets for category definition are uninformative or mixed).  
 
For step 5 (“Perform an internal assessment of the category”), the output of QSAR modelling 
introduced and considered as outlined above can contribute to trend analysis for compounds in the 
series both for those for which there are data and those for which there are not. Through measures of 
similarity, it can also contribute to delineation of the bounds of the category. 
 
For step 6 (“Prepare category test plan”), where critically evaluated output of QSAR contributes 
meaningfully to trend analysis, it may obviate the need for testing of certain members of the category. 
Rationales need be based on well documented critical evaluation of the output of batteries of models, 
with clear delineation of strengths and limitations and take into account availability for other 
members of the category and consistency overall of critically evaluated QSAR output and data. 
 
For step 8 (“Perform an external assessment of the category”), the principles outlined above for 
consideration of QSAR in development of the test plan are also relevant in considering their 
contribution to the initial assessment. This contribution must necessarily be based on critical 
evaluation of the output of a suite of models, based on an understanding of their relative limitations 
and strengths for the specified application. 
 
Guidance on different types of categories 
 
Chain length  
 
These are defined as categories showing an incremental, and usually constant, increase in chain 
length across the category.  There is an assumption that each category member exhibits the same toxic 
mode of action.  Examples are the homologous series of alpha-olefins where each category member 
differs by a –CH2- unit and the ethylene glycols where there is an incremental increase in the 
CH2CH2O group.   
 
Categories defined by chain length generally show an incremental change in molecular weight and 
other physico-chemical properties such as water solubility or Log Kow.  However, not all properties 
will necessarily exhibit a linear relationship with chain length and care must be taken in making 
assumptions about such trends. Careful thought should be given to selecting the boundaries of a chain 
length category.  The cut-off points described above may provide useful boundaries.   
 
QSARs can be used to help justify the category and fill data gaps.  In general, substances at either end 
of a chain length category should have all endpoints fulfilled, preferably with test data.  This permits 
interpolation of data to the other category members rather than extrapolation and increases confidence 
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in the read-across. For example, a linear regression has been used to predict acute aquatic toxicity of 
long chain alcohols.  For categories where there is more than one variable, such as variation in chain 
length and degree of branching of the chains, more category members are likely to be required to 
bring confidence to the interpolations being made.   
 
 
Metabolic pathways 
 
The underlying hypothesis for a metabolic series is a sequential metabolism of a parent chemical to 
downstream blood metabolites that are chemicals of interest.  Hazard identification studies with the 
parent compound could then be used to identify the hazards associated with systemic blood levels of 
the downstream primary and secondary metabolites and once quantified, can be used in place of 
studies using direct exposure to primary and secondary metabolites themselves.  In certain 
insistences, the metabolism of the parent compound within barrier tissue (e.g. lung or gut tissue) 
occurs so rapidly that the initial primary metabolite is the predominate chemical found within the 
blood.  Under these circumstances data from hazard identification studies conducted with that 
primary metabolite itself can be used to identify hazards for the parent compound. 
The first technical issues faced when forming a metabolic series is to determine if the metabolism that 
is assumed to occur does occur.  This is necessary before moving any further in developing a 
metabolic category and preferentially should be determined in vivo.  In certain instances, in vitro 
metabolic studies can be used to help identify metabolic pathways, but the definitive evidence should 
be conducted in whole animals.  The primary and secondary metabolites should be detected either in 
the blood or tissue.  Primary and secondary metabolites that cannot be readily determined in blood or 
tissue should not be candidates for a metabolic series approach without some limitation placed upon 
the use of the information. 
The second technical issue pertains to the level of evidence required to describe the metabolic 
processes.  Direct measurement of the parent chemical and primary and secondary metabolites in the 
blood in an in vivo exposure is the recommended standard.  The level of evidence required to 
presume that there will be blood born levels of primary and secondary metabolites following 
exposure to parent chemical, will have to be determined on a case by case basis.  Certain metabolic 
processes are ubiquitous and well understood and these can be presumed to occur without performing 
in vivo experiments in every instance.  Other metabolic processes are not part of normal metabolism 
or require enzyme induction. These metabolic processes may not be well characterized and should not 
be assumed without specific in vivo evidence of blood levels of primary and secondary metabolites. 
The third technical issue provides a limitation for the metabolic approach to forming categories.  The 
metabolic category reasoning is only useful for identifying hazards related to systemic blood levels of 
the parent compound and/or primary and secondary metabolites.  Other endpoints of hazard 
identification studies that are dependent upon site of contact effects (e.g. eye, skin, respiratory tract 
irritation, irritation to gastric mucosa) cannot be addressed using the metabolic category logic.  These 
sites of contact effects are often due to the physical chemical property of the chemical in question and 
therefore may differ considerably between the parent compound and primary and secondary 
metabolites.  In addition, tests that identify unique structural characteristics (e.g. skin or respiratory 
sensitization) or are dependant upon physical chemical properties (e.g. volatility and LC50 values) 
should not be considered as part of metabolic category because these properties may not be similar 
amongst the various members of the metabolic series. 
An additional limitation of metabolic categories approach is that metabolism and toxicokinetics 
experiments have to be conducted with the parent compound.   
An additional advantage of using the metabolic category toxicity data is that in certain instances, 
higher systemic blood levels of a chemical can be achieved from metabolic pathways than if the 
primary or secondary metabolite was administered directly.  For example, if a material is corrosive or 
has limited volatility, higher blood levels may be found following the administration of the parent 
compound than if the primary or secondary metabolite was administered directly to the animal. 
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The following specific issues should be taken into account when developing a metabolic pathway 
category. 
− at step 1:  Provide definitive information on the metabolism of the parent chemical to 
the primary and secondary metabolite.  This information should also include, 
preferably, a time course data for either blood or tissue for both the parent chemical as 
well as the primary and secondary metabolites. 
The metabolic approach should not be used for environmental toxicity endpoints unless the 
metabolism of the parent compound to the primary or secondary metabolite can be demonstrated 
within the test species in question.  Whereas it may be appropriate to extrapolate within mammals, it 
may not be appropriate to extrapolate between amphibia and fish or insects and other species due to 
the difference in the metabolic processes and enzymes present within those species.  
 
On the other hand the same concept underlying the metabolic pathways can be used for 
environmental degradation processes. For example, for a substance which hydrolyses very rapidly in 
aquatic test systems (half-life < 1 hour), the aquatic toxicity endpoints can be covered by the test 
results with the degradation product(s). 
 
 
Chemical mixtures 
 
Categories can sometimes apply to series of chemical reaction products or chemical mixtures that are, 
again, related in some regular fashion.  Analogous to the basic “discrete chemical” category model, in 
a mixture category some, but not all, of the individual mixtures may undergo testing.   
 
Isomers and their mixtures 
 
Isomers are chemicals that have identical molecular formula but different molecular arrangements. 
Although there are several types of isomers, the two that typically will be considered within the HPV 
Chemicals Programme are structural and geometric. 
Structural isomers are molecules with differences in the arrangement of their atoms, such as butene-1 
and isobutene. Structural isomers can include: 
• chain isomers, for example hydrocarbon chains with identical or variable lengths and variable 
branching patterns 
• positional isomers, for example hydrocarbon chains with a functional group that varies in position 
along the chain 
A third type of structural isomer is referred to as a functional group isomer. These isomers also have 
identical molecular formula, but contain different functional groups. Examples of two functional 
group isomers with C4H10O as a molecular formula are 1-butanal and 2-butanone. Each of these 
isomers contain a carbonyl group (C=O), but are representative of two different chemical families, 
aldehydes and ketones. Although structural isomers, this type is less likely to be considered within a 
category for the Programme because functional isomers can have very different chemical and 
biological properties.  
There are general rules for using read-across techniques as they apply to isomers: 
• Relatedness - The substance(s) without data as well as the substance(s) with data are similar such 
that their physicochemical, biological, and toxicological properties would be expected to behave 
in a predictably similar manner or logically progress across a defined range. 
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• Structural Similarity - The substance(s) without data possesses a small incremental structural 
difference from the reference substance(s) or the difference between the two would not be 
expected to affect the property sufficiently such that it could not be accurately predicted. 
There can be instances within a category of isomers, specifically as related to structural isomers, 
when read-across for an endpoint is not appropriate.  
 
Complex substances 
 
Complex substances include a diverse range of materials which are frequently described as substances 
of Unknown or Variable composition, Complex reaction products or Biological material (UVCB 
Substances). There are many different types of complex substances, though generally they all have 
the following characteristics in common.  
• They contain numerous chemicals (typically closely related isomers), and cannot be 
represented by a simple chemical structure or defined by a specific molecular formula. They 
are, however, assigned unique Chemical Abstract (CAS) numbers (see note1 below about 
unique issues with CAS numbers for UVCB substances). 
• They are not intentional mixtures of chemicals.  
• Many are of natural origin (e.g., crude oil, plant extracts) and cannot be separated into their 
constituent chemical species. 
• The concept of “impurities” typically does not apply to complex substances. 
Category approaches for complex substances may vary, though generally the approach will be related 
to how the substances are manufactured, defined and used.  This approach is practical and has the 
benefit of making sure that similar commercial products are grouped together in the same category. 
• It is important to clearly characterise mixtures, details of the production process can be 
useful. It is necessary to identify the following attributes of a complex mixture: 
o Components (what is present in the mixture) 
o Composition (what is present and in what proportion) 
o Impurities (substances present that are not wanted but need to be identified) 
• Properties of the components of a complex mixture can be applied to the complex mixture if 
the properties of the single components are similar. 
o It is necessary to identify representative components of the mixture to cover the 
carbon range and structures of the mixture. 
o Components with outlying properties need to be identified (e.g. specific toxicity of 
hexane compared to other aliphatic hydrocarbons, higher water solubility of aromatic 
hydrocarbons compared to aliphatic hydrocarbons). 
• Properties of a complex mixture can be read-across to another complex mixture if the 
composition of the two are similar. 
• Quantitative read-across is more difficult (ranges can be used where applicable).It is 
necessary to carefully consider the dose for read across because of the nature of the mixtures 
and the amount of components of concern.  
• It is necessary to carefully identify representative substances for testing purposes. 
 
Metal and metal compounds 
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The concept of chemical categories has traditionally been widely used for inorganic substances. 
However, there is not much experience is available to date of a systematic use of this approach. There 
are a number of assumptions underlying any grouping of metal compounds for estimating their 
biological properties. The main assumption is that it is the metal ion that is responsible for the effects 
to be assessed. This is considered to be a reasonable assumption for the majority of the inorganic and 
some organic anions. This implies that in the case of inorganic salts, the toxicity of the anion is 
assumed to be largely irrelevant in producing the effects to be assessed. Where a metal can have 
different valence states (e.g. chromium), the toxicities of the different valence states may vary, and 
the different valence states considered separately.  
 
The water solubility of the metal compounds is often used as the starting point for establishing a 
category, as this reflects the availability of the metal ion in the different compartments of interest.  
• The main assumption is that the metal ion (or ion complex) is responsible for the effects to be 
assessed (the toxicity of the counter-ion is assumed to be largely irrelevant in producing the 
effects to be assessed). 
• One basis of grouping could therefore be water solubility (inorganic metal compounds), 
taking into account: 
o transformation/ dissolution of insoluble compounds 
o bioavailability of the metal ion in the environment 
o solubility in biological fluids 
o persistence in the body 
• The assumption that the metal ion (or ion complex) is mainly responsible for the effects 
rather than the counter-ion may not work for local mammalian toxic effects. 
• Possible differences in the toxicity of different oxidation states of the metal ion (or ion 
complex) should be considered. 
• Whilst the assumptions shown above can be expected to be valid for a wide range of 
inorganic compounds, these do not necessarily apply to organically based metal compounds. 
A different approach may be needed for grouping organic metal compounds. . 
 
Similar considerations would also apply to salts of anions where there are concerns for toxicity (e.g. 
cyanides, oxalates). 
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USE BY US EPA 
Chemical Categories 
The chemical categories are a good reflection of what is “knowledge within the EPA”. The categories 
are typically biased towards environmental endpoints with limited justication for how the category or 
its members were selected. Human expert judgement is used to devise these categories. Prior to 1987, 
nearly 20% of Pre Manufacture Notifications (PMNs) submitted underwent a detailed review 
("standard review") by EPA, a highly resource-intensive effort that lasted most of the mandated 90-
day PMN review period. In 1987, after several years of experience in the review of PMNs, EPA's 
Office of Toxic Substances (now the Office of Pollution Prevention and Toxics) had enough 
accumulated experience to group PMN chemicals with shared chemical and toxicological properties 
into categories, enabling both PMN submitters and EPA reviewers to benefit from the accumulated 
data and past decisional precedents allowing reviews to be facilitated. Candidate categories for the 
New Chemicals review process are proposed by New Chemicals Program staff, based on experience 
reviewing PMNs on similar substances. At proposal, the database supporting the category is 
scrutinized for quality and for general applicability to other potential members of the category. Based 
on this analysis, a category statement is prepared describing the molecular structure. Boundary 
conditions such as molecular weight, equivalent weight, the log of the octanol/water partition 
coefficient (log P), or water solubility, that would determine inclusion in (or exclusion from) a 
category, and standard hazard and fate tests to address concerns for the category are all considered. 
The categories may not be made up of the most hazardous chemicals, but rather include chemicals for 
which sufficient history has been accumulated so that hazard concerns and testing recommendations 
vary little from chemical to chemical within the category. The categories are not intended to be a 
comprehensive list of all substances. The 64 categories are listed in the following table. A couple of 
example category descriptions are presented underneath. 
Acid 
Chlorides 
Anhydrides, 
Carboxylic 
Acid 
Cationic 
(quaternary 
ammonium) 
surfactants 
Hindered 
Amines 
Peroxides Respirable, 
Poorly Soluble 
Particulates 
Acid Dyes 
and 
Amphoteric 
Dyes 
Anilines Cobalt Imides Persistent, 
Bioaccumulat
ive, and 
Toxic (PBT) 
Chemicals  
 
Rosin 
Acrylamides Dianilines Diazoniums Diisocyanates Phenolphthal
eins 
Stilbene, 
derivatives of 
4,4-bis(triazin-
2-ylamino)-  
Acrylates/M
ethacrylates 
Anionic 
Surfactants 
Dichlorobenzidin
e-based Pigments 
ß-
Naphthylamine
s, Sulfonated 
Phenols Thiols 
Aldehydes Azides Dithiocarbamates Lanthanides or 
Rare Earth 
Metals 
Phosphates, 
Inorganic 
Substituted 
Triazines 
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Aliphatic 
Amines 
Benzotriazoles Epoxides Neutral 
Organics 
Phosphinate 
Esters 
 
Triarylmethane 
Pigments/Dyes 
with Non-
solubilizing 
Groups 
 
Alkoxysilan
es 
 
Benzotriazole-
hindered 
phenols 
 
Esters 
 
Nickel 
Compounds 
 
Polyanionic 
Polymers (& 
Monomers) 
 
Vinyl Esters 
 
Aluminum 
Compounds 
 
Boron 
Compounds 
 
Ethylene Glycol 
Ethers 
 
Nonionic 
Surfactants 
 
Polycationic 
Polymers 
 
Vinyl Sulfones 
 
Soluble 
complexes of 
Zinc 
Aminobenzo
thiazole Azo 
Dyes 
 
Cationic Dyes 
 
Hydrazines and 
Related 
Compounds 
 
Organotins 
 
Polynitroaro
matics 
 
Zirconium 
Compounds 
 
Category: Acid Chlorides Environmental Toxicity  
Definition. This category includes carbonyl chlorides (R-C[=O]Cl) and sulfochlorides (R-S[=O]Cl) 
where R may be either aliphatic or aromatic. Toxicity is limited by the fact that this class of 
compounds hydrolyzes and also, probably, if the octanol/water partition coefficient (Kow) is above a 
log Kow value of 8. It has been assumed that these compounds need to be absorbed to be toxic, 
therefore, compounds with MWs > 1000 will probably be excluded in the future once this assumption 
is confirmed with toxicity information. However, toxicity information is needed to confirm this 
assumption.  
Hazard Concerns. Acute toxicity for three members of this category are available and all have been 
shown to be moderately toxic to aquatic organisms (i.e., acute toxicity values between 1 and 100 
mg/L): benzoyl chloride, fish 96-h LC50 = 35.0 mg/L, an aromatic dicarboxyl dichloride, fish 96-h 
LC50 = 6.2 mg/L, and benzene sulfochloride, fish 48-h LC50 = 3.0 mg/L. All of these tests have been 
done with the static method using nominal concentrations. It is unclear just how acid chlorides are 
toxic to aquatic organisms. It is known that acid chlorides hydrolyze to the carboxylic/sulfonic acid 
and HCl. It is not known if the toxic effect is the result of (1) absorption of the acid chloride and 
hydrolysis within the membrane, or (2) the HCl produced from the hydrolysis. It is known that the 
carboxylic/sulfonic-acid hydrolysis products are of low toxicity.  
Boundaries. There are no known lower boundaries. The upper boundaries will be based on Kow and 
MW when enough information is obtained. In general, when the log Kow value is < 8, the 
environmental base set of tests will be requested for aquatic releases and the terrestrial base set of 
tests will be recommended for terrestrial exposures. When the log Kow is > 8, testing will be requested 
until enough information is obtained to determine whether these compounds will have no toxic effects 
at saturation. Generally, members of this category will have MWs of less than 1000 but testing of 
members with a MW > 1000 may be requested to confirm whether acid chlorides have to be absorbed 
to be toxic.  
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General Testing Strategy. The testing strategy for acid chlorides will consist of two steps. (1) 
Hydrolysis as a function of pH at 25 C (40 CFR 796.3500) will be recommended. Depending on the 
outcome of this environmental fate testing and reassessment, (2) the aquatic base set of environmental 
toxicity tests will be recommended for aquatic exposures with the fish acute toxicity test done once or 
twice.  
Chronic toxicity testing for aquatic organisms include: the fish early life state toxicity test, the 
daphnid partial life cycle toxicity test and the algal toxicity test.  
The terrestrial base set of environmental toxicity tests (i.e., the early seeding growth test, the 
earthworm acute toxicity test and the soil microbial community bioassay) will be recommended for 
terrestrial exposures. Chronic toxicity testing for terrestrial organisms include: the plant whole life 
cycle test, the plant uptake test, and the soil microbial community bioassay.  
Category: Alkoxysilanes Human Health, Environmental Toxicity  
Definition. Any molecular structure containing one or more of the following reactive groups is 
considered to be a member of the category.  
 
The "typical" new chemical of concern is a polymer with a substantial fraction of species with 
molecular weights <1000 and pendant trimethoxy- or triethoxysilane groups.  
Hazard Concerns.  
Health - Concern for lung toxicity from inhalation of vapors or aerosols is based on data for a number 
of low-molecular-weight alkoxysilanes. Trimethoxysilane (TMS) is clearly the most toxic member of 
the class causing irreversible lung effects at low doses, but the Agency does not consider it 
appropriate to use TMS as a regulatory benchmark for all alkoxysilanes. For trimethoxysilane 
monomers and polymers with a low trimethoxysilyl equivalent weight, a NOAEL of 10 ppm (about 
11 mg/kg/day) based on a 90-day study with vinyltrimethoxysilane in monkeys is deemed an 
appropriate generic benchmark. Alkoxysilanes in which the alkyl substituent is not a methyl group do 
not appear to be as toxic as methoxysilanes. The New Chemicals Program currently uses a generic 
benchmark NOAEL of 75 mg/kg/day, based on a 90-day inhalation study with 
tri(isopropenoxy)silane, for alkoxysilanes other than methoxysilanes.  
Ecotoxicity - Alkoxysilanes are highly toxic to algae and moderately toxic to aquatic invertebrates. 
For example, the daphnid 48-hr LC50 for dimethyldiethoxysilane is 1.25 mg/L, and the 15-day algal 
EC95's for vinyltriethoxysilane, tetraethoxy-silane, and trifluoropropenyl(methyl)diethoxysilane are all 
approximately 10 µg/L.  
Boundaries. Methoxy- and ethoxysilanes are presumed not to pose a hazard under any conditions if 
the equivalent weight is 5,000 and no more than 25% of species have molecular weights less than 
1,000 and no more than 10% of species have molecular weights less than 500. For alkoxysilanes with 
alkyl substituents larger than propyl groups, the equivalent weight cutoff is 1,000. The degree of 
concern depends on the relative abundance of lower molecular weight species, but there is no 
molecular weight threshold above which there would be no concern.  
To better define the boundaries of the category, EPA seeks testing on a limited number of 
alkoxysilanes that focuses on (1) the relationship between molecular weight (or alkoxysilyl equivalent 
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weight) and inhalation toxicity and (2) the importance of increasing alkoxy chain length in limiting 
toxicity.  
General Testing Strategy  
The Agency recommends the following testing as appropriate to address health and environmental 
toxicity concerns for this category:  
1. 90-day subchronic test in rodents by the inhalation route (40 CFR 798.2650).  
2. Hydrolysis testing (40 CFR 796.3500). If t1/2 is less than one hour, base set ecotoxicity testing (see 
"3," below) is conducted with the hydrolysis products only. If t1/2 is greater than one hour, base set 
ecotoxicity testing is conducted with the parent material; the PMN submitter has the option of also 
testing with the hydrolysis products.  
3. Base-set ecotoxicity testing to include fish (40 CFR 797.1400) using the static method, daphnids 
(40 CFR 797.1300) using the static method and algae (40 CFR 797.1050) using the static method, all 
nominal concentrations. Direct dilution of the test alkoxysilane and organisms is added within 10 
minutes. The static-renewal method is used for fish and daphnid test, plus an additional fish test using 
aged stock solution.  
Results of the acute ecotoxicity testing may trigger chronic fish (40 CFR 797.1600) and daphnid (40 
CFR 797.1350) testing.  
4. Physical-chemical or environmental fate testing including, as appropriate, melting point (40 CFR 
796.1300) or boiling point (40 CFR 796.1220), water solubility (40 CFR 796.1840 or 796.1860), log 
Kow (40 CFR 796.1550, 796.1570 or 796.1720), vapor pressure (40 CFR 796.1950), direct photolysis 
and indirect photolysis (40 CFR 796.3765). Need for water solubility, log Kow, and photolysis testing 
determined by outcome of above hydrolysis testing.  
Analog Identification Methodology (AIM) 
The US EPA have no tools to identify or predict the toxicity of non cancer health endpoints. Instead 
read across arguments are used to assess and identify particular hazards. To facilitate read across a 
methodology know as AIM has been developed to help identify potential analogs of interest. The 
AIM approach comprises a large database of 31,031 compounds with publicly available toxicity data 
from a variety of sources. These compounds have been coded for the presence of 645 structural 
fragments and correction factors taken from the EPISuite KOWWIN program. Chemicals have also 
been coded with a ring index to enable faster retrieval.  
During a search for potential analogs with available toxicity information, AIM assigns structural 
fragments, correction factors and the ring index to the compound of interest using the exact same 
algorithms as have been used to develop the database. The program uses a “three-pass” methodology 
to locate at least seven analogs and a maximum of 48 analogs. 
• Pass 1- Analogs are selected when an exact match for all fragments, corrections and ring 
types occurs. If seven or more analogs are located, the search is terminated and the list of 
analogs is provided.  
• Pass 2 - looks for additional analogs if less than seven analogs were located in pass 1. In this 
pass, analogs are selected based on two techniques. The first allows for different substitution 
patterns for alkyl substituents to be considered analogs. The second requires an exact match 
for only 262 structural fragments.  
• Pass 3 - looks for additional analogs if less than seven analogs were located in pass 2. This 
pass allows halogen (chlorine, bromine, or iodine) substitutions between the compound of 
interest and analogs.  
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Known Limitations  
• Rings - The current AIM methodology requires exact matching with respect to rings in the 
candidate compound. No substitutions are allowed (e.g. phenyl ring for a pyridine ring). The 
same number of rings is also required (e.g. dichlorodiphenylsilane will not be identified as an 
analog for trichlorodiphenylsilane). Methodology to remove this limitation is under 
investigation.  
• Number of analogs included in the analog list - If Pass 1 locates seven or more analogs, Pass 
2 and Pass 3 are not currently implemented; therefore, some additional good analogs may not 
appear in the results.  
The current implementation of Pass 2 (and Pass 3) can add a sizeable number of analogs to the list. 
AIM is still in a beta test phase and extension and further development depends on input and feedback 
from beta testers. The tool itself is a simple means of identifying analogs (that have some toxicity 
data available) for read across. The tool does not categorise or rank the analogs returned. It is up to 
the individual user to decide when a specific analog is appropriate; no guidance to assist in this 
evaluation is available. The toxicity test data available is accessed in the form of hyperlink pointers. It 
is not structured in any way and cannot be downloaded into Excel or other tools for analyses and 
hypothesis testing. Some hyperlinks merely point to a general webpage e.g. IUCLID homepage or 
RTECS homepage so the user may need the appropriate licenses in order to be able to extract any 
available information. The pointer merely informs that there is a record for the chemical returned but 
not the type of data or its potential usefulness. AIM may be flexibly searched on the basis of 
structure, SMILES and CAS number though it cannot be searched by name.  
There is no information to represent the chemical distribution within the AIM database. A visual 
representation to demonstrate the content of the database in terms of organics/inorganics or different 
classes of chemicals would be of considerable value to understand the scope/domain of the database.  
 
References 
http://www.epa.gov/oppt/newchems/pubs/chemcat.htm 
 
USE BY CANADA 
Environment Canada uses the following general rules of thumb but recognises that there will always 
be exceptions.  
 
An analogue should preferably contain most, if not all, of the same structural features as the DSL 
(Domestic Sustances List) substance of interest.   
• An analogue should have approximately the same molecular weight as the substance.  
 
• An analogue should have water solubility similar to that of the substance of interest.  
 
• For persistence, an analogue should have the same reactivity or stability as the DSL substance of 
interest.  
 
• For an endpoint of interest, the relevant molecular descriptors of an analogue should be of 
comparable value to those of the substance.  
 
It is recognised that different analogues may be selected for different endpoints, e.g. an analogue 
selected for a P endpoint may not be suitable for determining a B endpoint). Environment Canada and 
Health Canada rely on many of the on-line databases, but have also created extensive in-house 
databases for physical-chemical properties and toxicity that are searchable by structure using the 
Chemfinder software (http://chemfinder.cambridgesoft.com) or ISISBase 
(http://www.mdli.com/products/framework/isis_base/index.jsp).  Most property and toxicity data for 
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new substances are stored in these databases and a large analogue database has been created by 
Environment Canada for DSL Categorisation.  
Use of read-across and categories by Health Canada 
The Canadian Environmental Protection Act, 1999 (CEPA 1999) requires categorization of the 
approximately 23 000 substances on the Domestic Substances List (DSL) prior to a legally mandated 
deadline of September 14, 2006.  
The objective of categorization is to identify substances (on the basis of either exposure or hazard) 
that need further assessment. The two phases of assessment are screening assessment and in-depth 
assessment. 
In order to efficiently identify and prioritize substances on the DSL that represent highest priorities 
from a human health perspective, a framework based on an iterative application of increasingly 
discriminating (i.e., simple and complex) tools for consideration of exposure and hazard was 
developed. The “simple tools” are sufficiently robust to address all substances on the DSL based on 
limited information; the “complex tools (ComHaz)”are more discriminating. Stepwise application of 
these tools minimizes over emphasis on data-rich compounds, while making optimum and efficient 
use of available information. 
The complex hazard tool so-called ComHaz involves a hierarchical consideration of various sources 
of information (including data, [quantitative] structure–activity analysis and comparison with 
analogues) for a range of endpoints of toxicity. 
 
Complex Hazard tool (COMHAZ) 
 
In the Complex Hazard Tool (ComHaz), information on a variety of types of health effects identified 
from various sources is considered in a hierarchical manner. 
 
This tool covers a range of toxicological endpoints considered in a stepwise manner and includes 
criteria specific to each endpoint. These endpoints have been selected based on consideration of 
potential public health impacts, as well as the likelihood of availability of relevant information. The 
endpoints, which are listed below, are considered in descending order 
 
Endpoints included in the hierarchical approach are: 
1. carcinogenicity; 
2. genotoxicity; 
3. regulatory/reference values; 
4. developmental toxicity; 
5. reproductive toxicity; 
6. longer-term toxicity; 
7. short-term toxicity; and 
8. acute toxicity. 
 
 
The available information on these effects is considered in sequential order, beginning with 
carcinogenicity. If any of the information satisfies the criteria for an endpoint, the substance is 
prioritized for further consideration in subsequent stages, which include a preliminary assessment of 
weight of evidence for qualitative endpoints and development of measures of exposure–response for 
critical effects. If the criteria are not satisfied or insufficient data relevant to that endpoint are 
identified, the available information on the next endpoint is considered.  
 
For regulatory/reference values (generally based on longer-term studies), longer-term toxicity, short 
term toxicity and acute toxicity, if information is sufficient but does not meet the criteria, it is not 
necessary to consider steps lower in the hierarchical approach, and the substance can be “Set Aside” 
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for no further consideration at this time. Substances can be “Set Aside” based on regulatory or 
reference values, because these values are generally based on lowest- or no-effect levels for critical 
effects identified through comprehensive assessments of the available data. 
 
Setting substances aside on the basis of longer-term, short-term and acute toxicity is predicated on the 
toxicological principle that the amount of a substance required to induce health effects generally 
decreases with increasing duration of exposure, and more sensitive effects are likely to be discernible 
in longer-term studies. Thus, if a substance is deemed not to be of concern for longer-term toxicity 
(on the basis of comparison of adequate information with the quantitative criteria in ComHaz), it is 
unlikely to be of concern for effects induced following exposures of shorter duration. 
 
Once a substance is prioritized for further consideration on the basis of a given endpoint, there is no 
need to consider available information on endpoints that are lower in the sequence at this initial stage. 
This approach permits the initial prioritization of a large number of substances in an efficient and 
effective manner. While a substance may be prioritized for further consideration without evaluation 
of the data available for every endpoint in the hierarchy, data on all relevant endpoints will be 
considered during subsequent phases. If the available information on a substance does not meet the 
criteria specific to any of the components considered in the hierarchy, the substance is considered to 
be of low toxicity based on this conservative tool, and it is “Set Aside” at this time, with no 
requirement for further consideration. However, in some cases, substances “Set Aside” at this time 
may be reconsidered at some later date in the light of additional data. 
 
 
Hierarchical Consideration of Sources of Information 
 
Various sources of toxicological information are considered to determine if a substance meets the 
endpoint-specific criteria proposed for ComHaz. These sources of information are also considered in 
a hierarchical fashion in descending order of degree of confidence, in that acceptable assessments of 
international or national agencies and secondary reviews are first consulted, followed by original 
study accounts, predictions of quantitative structure–activity relationship (QSAR) models, 
information on chemical substructures of concern and analogues or surrogates (Figure 1) 
 
If no relevant toxicological data are identified, QSAR models are used to predict the likelihood that a 
substance will induce adverse effects on health. Of the various commercially available QSAR models 
identified, those proposed for use in the first stage of ComHaz currently include the statistically based 
TOPKAT and/or CASETOX models for carcinogenicity, genotoxicity, developmental toxicity, 
chronic toxicity and acute toxicity. 
 
Use of SARs and read-across 
 
In cases where insufficient information from assessments or reviews of other agencies, primary study 
accounts or QSAR predictions is available to permit a conclusion with respect to initial prioritization 
of a substance on the basis of the toxicological endpoints included in the proposed hierarchical 
scheme (including reference values established by other agencies), substances are examined to 
determine if they contain chemical structures or structural subfragments that have been correlated 
with toxicity, based on comparison with other sources of information. These sources include non-
quantitative structure–activity relationship (SAR) models (e.g., automated expert systems such as 
DEREK), lists of chemical substructures of concern compiled by other agencies (excluding those 
identified by DEREK) (see Table) and extrapolation of toxicity information on analogue or surrogate 
substances identified using relevant databases and automated structure or substructure search engines 
(e.g., Accord, Leadscope). Substances containing substructures of concern associated with endpoints 
considered relevant in the hierarchical approach described above or for which appropriate analogues 
or surrogates are associated with these effects are prioritized for further consideration. Although these 
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sources of information are consulted only if the results of QSAR predictions are insufficient, this does 
not imply that there is greater confidence in predictions from QSAR models versus chemical 
structures of concern, automated expert systems or extrapolations from analogues. Many of the 
principles intrinsic to these sources of information are also incorporated into the commercial QSAR 
models. However, the ease of running and validating predictions from the commercial QSAR models 
and the range of endpoints (some for which predictions are quantitative) covered by these systems 
facilitate their direct incorporation into the ComHaz endpoint hierarchy so that large numbers of 
substances can be more efficiently evaluated. 
 
Considerations Relevant to Specific Groups of Substances 
 
Organic and Inorganic Acids, Bases and Salts 
 
The approaches to the application of ComHaz to organic or inorganic acids, bases and salts are 
dependent upon whether the substance in question is considered to be soluble or not. For the purposes 
of applying ComHaz, an organic or inorganic acid, base or salt is considered to be soluble if its 
measured or predicted solubility is ≥1 mg/litre. Alternatively, a qualitative determination that an acid, 
base or salt is soluble or very soluble may be made based on other information such as empirical data, 
thermodynamic calculations and computer modelling with the application of scientific professional 
judgement. 
 
When applying ComHaz, it is assumed that soluble acids, bases and salts can exist not only as intact 
substances, but also in alternate forms. For example, a soluble salt could be intact, 100% ionized or 
exist as the corresponding acid or base. When possible and considered appropriate, the alternate 
forms of soluble acids or bases and their salts can be grouped in order to take advantage of the data 
available on all of the substances in the group before making a determination of whether any 
substance in the group meets the criterion for a specific endpoint in ComHaz. For example, when 
insufficient information is available to reach a decision for a specific endpoint in the ComHaz 
hierarchy for a soluble acid, base or salt then data and QSAR model predictions for the alternate 
forms of the substance may be considered. In addition, when extrapolating from data on an alternate 
form of an acid, base or salt, previous decisions to either prioritize the alternate form for further 
consideration or set it aside for no further action may be taken into consideration  
 
Acids, bases and salts that are not soluble are considered in ComHaz in the same manner as simple 
organic substances. However, if inadequate data or model predictions necessitates the application of 
surrogate or analogue approaches, then preference is given to extrapolations based on data from 
surrogate or analogue substances that are not soluble.  
 
Scientific professional judgement must be considered when determining whether it is appropriate to 
reach a decision on an acid, base or salt for a specific endpoint in ComHaz based on an extrapolation 
from an alternate form of the substance, or surrogate or analogue substances. 
 
Mixtures 
 
If ComHaz is applied to a mixture and relevant data on the mixture as a whole are not identified for a 
given endpoint in the hierarchy, the individual components of the mixture may be considered 
separately in a manner similar to that outlined above for the alternate forms of a soluble acid, base or 
salt. Also, similar to the alternate forms of a soluble acid, base or salt, previous decisions to either 
prioritize a mixture component for further consideration or set it aside for no further action may be 
taken into onsideration when applying ComHaz to the whole mixture. 
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As outlined above, the application of ComHaz involves the comparison of information on a series of 
toxicological endpoints relevant to human health with endpoint-specific criteria that can be qualitative 
(e.g., carcinogenicity/genotoxicity) or quantitative (e.g., repeated-dose toxicity). For endpoints with 
qualitative criteria, where possible, in subsequent initial phases of screening, the data will be 
considered in a preliminary weight of evidence approach, the objective of which is to additionally 
discriminate priorities for further consideration without imposing undue workload, the latter being 
more appropriate to subsequent phases of screening and in-depth assessment. 
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Figure 1 ComHaz hierarchical consideration of sources of information 
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Figure 2 SARs used in ComHaz  
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RECOMMENDATIONS FOR FURTHER DEVELOPMENT OF GUIDANCE BY EU QSAR 
WORKING GROUP 
 
This review aims to outline and summarise some of the practical experiences from the major 
Regulatory agencies as well as the guidance so far developed by the OECD. 
This has helped inform where the strengths and limitations exist and where there are opportunities 
that could be further explored. 
Working in partnership with stakeholders from Health Canada and the US EPA would help to gain 
valuable practical experience about how category proposals are typically undertaken. 
Recommendations for next steps should include: 
• Review of the available approaches and/or tools for identifying analogs including descriptors 
for chemical similarity/structural keys/pharmacophores/fingerprints 
• Investigate the feasibility of how different chemical similarity descriptions can be applied to 
the identification of chemical groupings using one or more existing regulatory inventories 
• Based on such exploratory research work, solicit feedback from the working group to 
establish a “toolbox” of available and recommended approaches 
• Establishment of a small drafting team (comprising members from the ECB, the QSAR 
working group as well as stakeholders from Canada, US, OECD) to write a guidance 
document. This document should also include a compendium of case studies highlighting the 
strengths and limitations of a given approach for a specific purpose/endpoint 
